HC Wainwright & Co. Reiterates Buy on MoonLake, Maintains $50 Price Target
10/5/2026
Impact: 80
Healthcare
HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on MoonLake (NASDAQ: MLTX) and maintained a price target of $50 for the stock.
AI summary, not financial advice
Share: